Marshall; Shannon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Marshall; Shannon.The latest application filed is for "antibodies and other molecules that bind b7-h1 and pd-1".

Company Profile

1.14.18

Marshall; Shannon - Baltimore MD
Marshall; Shannon - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
B7-H4 fusion proteins and methods of use thereof Grant 9,957,312 - Langermann , et al. May 1, 2	2018-05-01
Anti-B7-H4 antibodies and their uses Grant 9,676,854 - Liu , et al. June 13, 2	2017-06-13
Antibodies And Other Molecules That Bind B7-h1 And Pd-1 App 20160130348 - Langermann; Solomon ; et al.	2016-05-12
B7-h4 Fusion Proteins And Methods Of Use Thereof App 20160039905 - Langermann; Solomon ; et al.	2016-02-11
Antibodies and other molecules that bind B7-H1 and PD-1 Grant 9,205,148 - Langermann , et al. December 8, 2	2015-12-08
FGFR extracellular domain acidic region muteins Grant 9,175,065 - Marshall , et al. November 3, 2	2015-11-03
B7-H4 fusion proteins and methods of use thereof Grant 9,011,853 - Langermann , et al. April 21, 2	2015-04-21
Anti-B7-H4 Antibodies and Their Uses App 20140356364 - Langermann; Solomon ; et al.	2014-12-04
Compositions And Methods Of Use For Mgd-csf In Disease Treatment App 20140170145 - Behrens; Dirk ; et al.	2014-06-19
Antibodies And Other Molecules That Bind B7-H1 And PD-1 App 20140044738 - Langermann; Solomon ; et al.	2014-02-13
Compositions and methods of use for MGD-CSF in disease treatment Grant 8,575,312 - Behrens , et al. November 5, 2	2013-11-05
Fgfr Extracellular Domain Acidic Region Muteins App 20130004492 - Marshall; Shannon ; et al.	2013-01-03
FGFR extracellular domain acidic region muteins Grant 8,338,569 - Marshall , et al. December 25, 2	2012-12-25
Compositions for treating arthritis comprising HG1023575 polypeptide Grant 8,324,165 - Penta , et al. December 4, 2	2012-12-04
B7-h4 Fusion Proteins And Methods Of Use Thereof App 20120276095 - Langermann; Solomon ; et al.	2012-11-01
Compositions and Methods of Use for MGD-CSF in Disease Treatment App 20120258071 - Behrens; Dirk ; et al.	2012-10-11
Compositions and methods of use for MGD-CSF in disease treatment Grant 8,178,109 - Behrens , et al. May 15, 2	2012-05-15
Methods Of And Compositions For Stimulation Of Glucose Uptake Into Muscle Cells And Treatment Of Diseases App 20110319324 - Lin; Junyu ; et al.	2011-12-29
Compositions and Methods for Treating Arthritis and/or Diseases Involving Cartilage Degeneration App 20110288024 - Penta; Kalyani ; et al.	2011-11-24
Compositions And Methods Of Use For Mgd-csf In Disease Treatment App 20110003384 - BEHRENS; Dirk ; et al.	2011-01-06
FGFR Extracellular Domain Acidic Region Muteins App 20100087627 - Marshall; Shannon ; et al.	2010-04-08
Compositions and Methods of Use for Mgd-Csf in Disease Treatment App 20070264277 - Behrens; Dirk ; et al.	2007-11-15
Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases App 20070054851 - Lin; Junyu ; et al.	2007-03-08
Generating protein pro-drugs using reversible PPG linkages App 20050079155 - Marshall, Shannon	2005-04-14
Ciliary neurotrophic factor variants App 20050064555 - Marshall, Shannon ; et al.	2005-03-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.